We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+12.2%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$895M
AUM Growth
+$108M
Cap. Flow
+$18.1M
Cap. Flow %
2.03%
Top 10 Hldgs %
70.52%
Holding
70
New
10
Increased
11
Reduced
4
Closed
–

Top Buys

Rank Stock Value
1
USB icon
US Bancorp
USB
+$5.79M
2
BNY
Bank of New York Mellon
BNY
+$3.49M
3
MO icon
Altria Group
MO
+$1.95M
4
BAC icon
Bank of America
BAC
+$1.25M
5
AME icon
Ametek
AME
+$1.1M

Top Sells

Rank Stock Value
1
CHL
China Mobile Limited
CHL
+$1.05M
2
FTV icon
Fortive
FTV
+$855K
3
GE icon
GE Aerospace
GE
+$230K
4
KHC icon
Kraft Heinz
KHC
+$48.7K

Sector Composition

Rank Sector Weight
1 Financials 46.57%
2 Healthcare 18.39%
3 Industrials 7.55%
4 Materials 6.6%
5 Technology 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRU icon
51
Prudential Financial
PRU
$42.2B
$496K 0.06%
+6,350
New +$459K
MRK icon
52
Merck
MRK
$322B
$481K 0.05%
+6,162
New +$471K
BMY icon
53
Bristol-Myers Squibb
BMY
$130B
$463K 0.05%
+7,460
New +$459K
AVXL icon
54
Anavex Life Sciences
AVXL
$325M
$462K 0.05%
85,585
– –
ECL icon
55
Ecolab
ECL
$79.8B
$454K 0.05%
2,100
– –
CHL
56
DELISTED
China Mobile Limited
CHL
$414K 0.05%
14,490
-33,810
-70% -$1.05M
OMC icon
57
Omnicom Group
OMC
$23.6B
$343K 0.04%
5,500
– –
NVCR icon
58
NovoCure
NVCR
$2.06B
$294K 0.03%
+1,700
New +$233K
GE icon
59
GE Aerospace
GE
$382B
$267K 0.03%
4,956
-5,132
-51% -$230K
TGTX icon
60
TG Therapeutics
TGTX
$7.64B
$260K 0.03%
+5,000
New +$169K
AKTX
61
Akari Therapeutics
AKTX
$13.5M
$166K 0.02%
112
– –
ALDX icon
62
Aldeyra Therapeutics
ALDX
$91.1M
$137K 0.02%
20,020
– –
ALPN
63
DELISTED
Alpine Immune Sciences Inc
ALPN
$132K 0.01%
10,445
– –
BDSI
64
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$105K 0.01%
25,000
– –
AMRN
65
Amarin Corp
AMRN
$296M
$73K 0.01%
750
– –
CRVS icon
66
Corvus Pharmaceuticals
CRVS
$1.24B
$71K 0.01%
19,959
– –
ADMA icon
67
ADMA Biologics
ADMA
$2.22B
$59K 0.01%
30,075
– –
1 2
3

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q4 2020 Portfolio in Review

As of Q4 2020, Hikari Power held 70 positions worth $895M, up 14% from $787M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Hikari Power's Q4 2020 filing shows 10 new, 11 increased and 4 reduced positions. Its largest new stake was Bank of America: 46,740 shares worth $1.42M. The largest sale was China Mobile Limited, an estimated $1.05M.

By sector, the portfolio is most concentrated in Financials at 47% of assets, up from 46% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q4 2020 buy was Bank of America: 46,740 shares worth $1.42M.
  • Hikari Power added most to US Bancorp in Q4 2020, an estimated $5.79M increase.
  • Hikari Power's biggest Q4 2020 reduction was China Mobile Limited, cutting an estimated $1.05M.
  • Hikari Power's ten largest holdings make up 71% of its $895M portfolio in Q4 2020.
  • Hikari Power opened 10 new positions and closed 0 in Q4 2020.
  • Hikari Power's portfolio value rose 14% quarter-over-quarter to $895M.

Based on Hikari Power's 13F filing for Q4 2020, filed 22 Jan 2021.